66.63
0.33%
-0.22
After Hours:
66.69
0.06
+0.09%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $66.63, with a volume of 12.31M.
It is down -0.33% in the last 24 hours and up +18.75% over the past month.
See More
Previous Close:
$66.85
Open:
$67.1
24h Volume:
12.31M
Relative Volume:
1.40
Market Cap:
$72.42B
Revenue:
$363.25B
Net Income/Loss:
$7.19B
P/E Ratio:
10.05
EPS:
6.63
Net Cash Flow:
$5.27B
1W Performance:
+3.16%
1M Performance:
+18.75%
6M Performance:
-4.46%
1Y Performance:
-7.11%
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-06-24 | Initiated | Barclays | Equal Weight |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Dec-22-23 | Initiated | HSBC Securities | Buy |
Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
May-26-23 | Initiated | Piper Sandler | Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Nov-23-22 | Resumed | Morgan Stanley | Overweight |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-14-21 | Initiated | Goldman | Buy |
Dec-01-21 | Initiated | Seaport Research Partners | Buy |
May-19-21 | Initiated | Wells Fargo | Equal Weight |
Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
Sep-17-20 | Initiated | Piper Sandler | Overweight |
Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-18-19 | Initiated | Guggenheim | Buy |
Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-10-19 | Reiterated | BofA/Merrill | Buy |
Mar-13-19 | Initiated | Bernstein | Outperform |
Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Jan-17-19 | Initiated | UBS | Buy |
Dec-18-18 | Initiated | Barclays | Overweight |
Nov-29-18 | Resumed | Goldman | Neutral |
Nov-28-18 | Initiated | Evercore ISI | Outperform |
Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Exclusive: CVS to exit core infusions services business, job cuts possible - Reuters
Exclusive-CVS to exit core infusions services business, job cuts possible By Reuters - Investing.com
CVS Health stock sees strong momentum with 70% membership in 4.5-star plans - Investing.com Canada
CVS Health’s Aetna recommended for new D-SNP contract by state of Michigan - TipRanks
Aetna recommended for new D-SNP contract by the State of Michigan – Company Announcement - Financial Times
While shareholders of CVS Health (NYSE:CVS) are in the red over the last three years, underlying earnings have actually grown - Yahoo Finance
CVS CEO heads to Revlon to lead ‘next phase of growth’ - TheIndustry.beauty
US health agency releases 2025 quality ratings for Medicare plans - Yahoo Finance
US health agency releases 2025 quality ratings for Medicare plans - Yahoo Canada Finance
Aetna shines in Star Ratings with 88 percent of Medicare Advantage members in 4-star plans or higher for 2025 - PR Newswire
See the list: Seven plans, compared to 38 last year, receive 5 stars in the Medicare Advantage Star Ratings - Healthcare Finance News
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst - Yahoo Finance
Top Stock Movers Now: Pfizer, First Solar, CVS Health, and More - Investopedia
CVS Health (NYSE:CVS) Shares Gap UpStill a Buy? - MarketBeat
Barclays ups CVS Health to Buy on positive margin outlook; shares rise - MSN
Barclays ups CVS Health to Buy on positive margin outlook; shares rise - Investing.com
Barclays ups CVS Health to Buy on positive margin outlook; shares rise - Investing.com UK
Barclays anticipates margin recovery for CVS Health, upgrades stock to overweight - Investing.com Canada
City Holding Co. Has $115,000 Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Analyst recommendations: CVS Health, Hubbell Inc, Lucid Group, Medtronic, PayPal... - Marketscreener.com
CVS, United Health Seek Removal Of FTC's Khan In PBM Case - Law360
CVS Health Corp. stock rises Wednesday, still underperforms market - MarketWatch
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit - Benzinga
CVS to lay off 416 employees at Aetna headquarters - Business Insurance
CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case - Reuters
CVS, UnitedHealth seek FTC recusal over bias in insulin case - Modern Healthcare
CVS Health Co. (NYSE:CVS) Shares Bought by Country Trust Bank - MarketBeat
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case - CNBC
Drug Middlemen Seek FTC Recusals Over Bias in Insulin Case - BNN Bloomberg
Evercore ISI Boosts CVS Health (NYSE:CVS) Price Target to $75.00 - MarketBeat
Cvs Health Supporting Customers, Patients, Members And Colleagues As Hurricane Milton Approaches - XM
CVS Health supporting customers, patients, members and colleagues as Hurricane Milton approaches - StockTitan
Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel - Yahoo Finance
CVS Health Corp.’s layoffs to hit CT for a second consecutive year. Nearly 100 local jobs to be cut. - Hartford Courant
Walgreens names Optum's Jason Stenta as chief commercial officer - Reuters
Fulton Bank N.A. Trims Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Instacart Is Revolutionizing Groceries: Why It's Time to Invest - Benzinga
CVS to lay off 632 workers tied to R.I. headquarters - Providence Business News
CVS Health contemplates strategic review amid business speculation - Business Insurance
Layoffs announced at CVS, over 600 RI-based jobs impacted. - Yahoo! Voices
More than 80 R.I. residents to lose jobs as part of CVS layoffs - Rhode Island Current
More than 80 R.I. residents to lose jobs as part of CVS layoffs - Yahoo! Voices
Pharmacy giant makes room for doctor care in CT store space. Will patients follow? - MSN
CVS Health to hold third quarter 2024 earnings conference call - StockTitan
CVS Health Corp (CVS): One of the Best Stocks to Buy According to Larry Robbins - Yahoo Finance
Is CVS Health Corp. (CVS) the Most Undervalued Large Cap Stock to Invest In Now? - Insider Monkey
Is CVS Health Corp. (CVS) the Most Undervalued Large Cap Stock to Invest In Now? - Yahoo Finance
Centaurus Financial Inc. Trims Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock? - Yahoo Finance
Czech National Bank Raises Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvs Health Corp Stock (CVS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Mahoney Michael F | Director |
May 02 '24 |
Buy |
54.49 |
9,181 |
500,294 |
9,356 |
Shah Prem S | EVP and Pres-Pharm, Consumer W |
Feb 16 '24 |
Sale |
76.95 |
29,473 |
2,267,947 |
39,765 |
LUDWIG EDWARD J | Director |
Nov 03 '23 |
Buy |
70.47 |
2,000 |
140,930 |
20,630 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):